Alvotech (ALVO) Income towards Parent Company (2021 - 2026)

Alvotech (ALVO) posted Income towards Parent Company of $1.0 million for Q1 2026, down 99.06% on a QoQ basis from $109.7 million in Q4 2025, and down 99.06% year-over-year from $109.7 million in Q1 2025.

Alvotech (ALVO) Income towards Parent Company (2021 - 2026) Analysis & Trends

Alvotech's Income towards Parent Company history runs 6 years deep, the most recent figure standing at $1.0 million for Q1 2026.

  • Quarterly Income towards Parent Company fell 99.06% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$165.1 million (up 38.58% YoY) and the FY2025 annual result came in at $109.7 million, up 144.43% from the prior year.
  • Income towards Parent Company was $1.0 million for Q1 2026 at Alvotech, down from $109.7 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at $264.7 million in Q2 2022 and bottomed at -$651.1 million in Q4 2023.
  • A 5-year average of -$91.4 million and a median of -$246152.0 in 2023 frame the typical range for Income towards Parent Company.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company slumped 362.17% — and 2025, when it jumped 51566.14%.
  • Alvotech's Income towards Parent Company stood at -$540.7 million in 2022, then retreated by 20.43% to -$651.1 million in 2023, then jumped by 65.69% to -$223.4 million in 2024, then soared by 149.1% to $109.7 million in 2025, then slumped by 99.06% to $1.0 million in 2026.
  • Business Quant data shows ALVO's Income towards Parent Company at $1.0 million in Q1 2026, $109.7 million in Q4 2025, and -$307.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Alvotech 907.91 Mn 907.91 Mn 5.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.03 Mn
Dec 31, 2025 109.68 Mn
Sep 30, 2025 -307.87 Mn
Jun 30, 2025 32.04 Mn
Mar 31, 2025 109.68 Mn
Dec 31, 2024 -223.39 Mn
Sep 30, 2024 -303.58 Mn
Jun 30, 2024 148.46 Mn
Mar 31, 2024 -213,111.00
Dec 31, 2023 -651.14 Mn
Aug 31, 2023 -86.85 Mn
Jun 30, 2023 138.48 Mn
Mar 31, 2023 -246,152.00
Dec 31, 2022 -540.69 Mn
Aug 31, 2022 -184.47 Mn
Jun 30, 2022 264.69 Mn
Mar 31, 2022 -58.90 Mn
Dec 31, 2021 206.23 Mn
Sep 30, 2021 -33.79 Mn